C12N 2770/20031
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2770/20031 (Uses of virus other than therapeutic or vaccine) appears on 4 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 14
- Assignees
- 12
- Inventors
- 69
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 2 |
| 2022 | 1 | 2 |
| 2023 | 0 | 4 |
| 2024 | 1 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for control of an infective disease with a vaccine24 Mar 2026US 12,583,890 B2Russellville Cardiology Consultants, P.A.
- Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics10 Jun 2025US 12,326,451 B2Institut Pasteur
- Antigen analogue for calibration of immunometric diagnostic assays22 Oct 2024US 12,123,875 B2Ortho-Clinical Diagnostics, Inc.
- Coronavirus vaccine8 Feb 2022US 11,241,493 B2CureVac AG
- Covid-19 and respiratory disease virus infection models using lung organoids3 Sep 2026US 2026/0259197 A1The Catholic University of Korea Industry-Academic Cooperation Foundation
- Sars coronavirus 2 recombinant vectors expressing reporter genes, derived from gh clade sars coronavirus 2 of korean isolate, and the production method therefor12 Mar 2026US 2026/0071190 A1RpexBio, Inc.
- Coronavirus vaccine, production and application5 Feb 2026US 2026/0034209 A1Turkiye Bilimsel Ve Teknolojik Arastirma Kurumu
- Stable cell clones harboring replicating sars-cov-2 rna7 Aug 2025US 2025/0250647 A1The United States of America, as represented by the Secretary, Department of Health and Human
- Systems and methods for characterizing pathophysiology24 Jul 2025US 2025/0237641 A1University of Washington
Most cited
By later US patents